DURHAM – Tellus Therapeutics, the neonatal care startup based in Durham, is raising a new round of funding and is almost halfway to its goal of $35 million. That’s according to an SEC filing. Tellus raised $35 million late last year as it continues in efforts to advance treatments...
Read More
RTP neonatal care company Tellus Therapeutics has successfully closed a $35 million Series A funding round to advance its drug candidates.
Read More
Tellus Therapeutics raised $2 million from a Boston firm, and plans to raise more, ahead of a clinical trial that could occur in 2022, the CEO tells WRAL TechWire.
Read More
ellus Therapeutics is pushing ahead with developing its neonatal brain injury treatment after landing crucial seed funding this week. Here are the details.
Read More
Tellus Therapeutics is getting closer to approval for its neonatal brain injury treatment. Here’s the latest.
Read More
A startup based on Duke University research that has a treatment to prevent infant brain injury has raised a debt round.
Read More
